Effect of adding dexmedetomidine as adjuvant to bupivacaine in ultra-sound guided erector spinae plane block for post modified radical mastectomy pain management

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202307885435649

Enrollment

Registered

2023-07-27

Start date

2023-07-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Erector Spinae Plane Block

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1- Age :30-65years. 2- Physical status: ASA I,II. 3- BMI<35. 4- Localized breast cancer.

Exclusion criteria

Exclusion criteria: 1- age:65 years. 2- Refusal of procedure or participation in the study by the patient. 3- Physical status: ASA III or above. 4- History of allergy to the study drug. 5- BMI>35. 6- Bleeding disorders and coagulopathy. 7- Psychiatric illness that may interfere with the study. 8- Metastatic breast cancer.

Design outcomes

Primary

Measure	Time frame
the first time to request rescue analgesia, pain score and patient hemodynamics.	—

Secondary

Measure	Time frame
The secondary outcome is to measure the total amount of nalubuphine consumed within 24 hours.	—

Countries

Egypt

Contacts

Public ContactAbanoub feltaoos

Assistant Lecturer in Department of Anesthesia Faculty of Medicine Ain Shams University

Abanoubmoureshabib@gmail.com+201283575659

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026